BUZZ-Nicox: Jumps on study results

Wed Jul 6, 2016 3:13am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** French ophthalmic company's shares up 11 pct on study phase 3 positive results

** Reported with Bausch + Lomb that latanoprostene bunod (LBN) ophthalmic solution 0.024 pct phase 3 study demonstrates significantly greater efficacy versus Timolol maleate 0.5 pct

** Stock on track for best day in >6 mo

** By far top performer of Euronext Next 150 (-0.5 pct)